Principal Financial Group Inc. boosted its stake in shares of Catalent Inc (NASDAQ:CTLT) by 21.7% during the second quarter, Holdings Channel reports. The firm owned 400,146 shares of the company’s stock after buying an additional 71,457 shares during the period. Principal Financial Group Inc. owned about 0.32% of Catalent worth $9,199,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the stock. Emerald Acquisition Ltd. purchased a new stake in shares of Catalent during the second quarter valued at approximately $123,000. LS Investment Advisors LLC increased its stake in shares of Catalent by 85.2% in the second quarter. LS Investment Advisors LLC now owns 7,131 shares of the company’s stock valued at $164,000 after buying an additional 3,280 shares during the period. Advisors Asset Management Inc. purchased a new stake in shares of Catalent during the second quarter valued at approximately $204,000. Strs Ohio increased its stake in shares of Catalent by 17.7% in the second quarter. Strs Ohio now owns 9,300 shares of the company’s stock valued at $213,000 after buying an additional 1,400 shares during the period. Finally, GSA Capital Partners LLP purchased a new stake in shares of Catalent during the second quarter valued at approximately $270,000.
Catalent Inc (NASDAQ:CTLT) opened at 23.40 on Tuesday. Catalent Inc has a 52 week low of $18.92 and a 52 week high of $32.24. The firm has a market cap of $2.92 billion and a price-to-earnings ratio of 26.29. The stock’s 50 day moving average is $25.23 and its 200 day moving average is $25.57.
Catalent (NASDAQ:CTLT) last issued its quarterly earnings results on Monday, August 29th. The company reported $0.52 EPS for the quarter, missing the consensus estimate of $0.53 by $0.01. The firm had revenue of $532.20 million for the quarter. During the same quarter in the previous year, the business posted $0.61 earnings per share. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. Equities research analysts expect that Catalent Inc will post $1.40 EPS for the current year.
Several research firms have weighed in on CTLT. Piper Jaffray Cos. reiterated an “overweight” rating and issued a $30.00 price objective (down previously from $30.50) on shares of Catalent in a research note on Tuesday, August 30th. TheStreet upgraded shares of Catalent from a “sell” rating to a “hold” rating in a research note on Wednesday, August 17th. Zacks Investment Research upgraded shares of Catalent from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 5th. Bank of America Corp. upgraded shares of Catalent from a “neutral” rating to a “buy” rating and set a $28.00 price objective on the stock in a research note on Monday, June 20th. They noted that the move was a valuation call. Finally, Stephens began coverage on shares of Catalent in a research note on Tuesday. They issued an “overweight” rating on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $28.67.
In related news, major shareholder Blackstone Management Associat sold 17,100,705 shares of Catalent stock in a transaction that occurred on Friday, September 9th. The shares were sold at an average price of $23.58, for a total transaction of $403,234,623.90. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Catalent Company Profile
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NASDAQ:CTLT).
Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.